Author: Der-Nigoghossian, Caroline; Ciolek, Alana; Chuich, Taylor
Title: Therapeutic Approach to Coronavirus Disease Cord-id: 9w9hp35d Document date: 2020_10_6
ID: 9w9hp35d
Snippet: The global pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), was first identified in Wuhan, China, in December 2019. The viral genome was rapidly identified in order to develop diagnostic testing and therapeutic options. SARS-CoV2 is a single-stranded RNA-enveloped virus that uses its surface spike (S) protein to bind host cell’s angiotensin converting enzyme 2 (ACE2) receptor in the presence of host cell protease TMPRSS
Document: The global pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), was first identified in Wuhan, China, in December 2019. The viral genome was rapidly identified in order to develop diagnostic testing and therapeutic options. SARS-CoV2 is a single-stranded RNA-enveloped virus that uses its surface spike (S) protein to bind host cell’s angiotensin converting enzyme 2 (ACE2) receptor in the presence of host cell protease TMPRSS2, a cofactor for virus entry [1]. The virus uses RNA-dependent RNA polymerase to synthesize RNA leading to viral assembly and exocytosis [2].
Search related documents:
Co phrase search for related documents- access program and action mechanism: 1
- access program and acute ards respiratory distress syndrome: 1
- access program and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
- access program and adjunctive therapy: 1
- access program and lung disease: 1
- access program and lung injury: 1, 2
- aceis enzyme inhibitor and acute sars cov respiratory syndrome coronavirus: 1, 2
Co phrase search for related documents, hyperlinks ordered by date